Cargando…

TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected Patients

Background: TRPM5 (transient receptor potential cation channel subfamily M member 5) rs886277 polymorphism has been related to liver cirrhosis from different etiologies. The present study investigates the association of TRPM5 rs886277 polymorphism with liver fibrosis progression and cirrhosis develo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Resino, Salvador, Fernández-Rodríguez, Amanda, Pineda-Tenor, Daniel, Gómez-Moreno, Ana Zaida, Sánchez-Ruano, Juan José, Artaza-Varasa, Tomas, Muñoz-Gómez, María José, Virseda-Berdices, Ana, Martín-Vicente, María, Martínez, Isidoro, Jiménez-Sousa, María A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865714/ https://www.ncbi.nlm.nih.gov/pubmed/33525598 http://dx.doi.org/10.3390/jcm10030483

Ejemplares similares

MTHFR rs1801133 Polymorphism Is Associated With Liver Fibrosis Progression in Chronic Hepatitis C: A Retrospective Study
por: Pineda-Tenor, Daniel, et al.
Publicado: (2020)

Impact of DARC rs12075 Variants on Liver Fibrosis Progression in Patients with Chronic Hepatitis C: A Retrospective Study
por: Jiménez-Sousa, María Ángeles, et al.
Publicado: (2019)

The Myeloid-Epithelial-Reproductive Tyrosine Kinase (MERTK) rs4374383 Polymorphism Predicts Progression of Liver Fibrosis in Hepatitis C Virus-Infected Patients: A Longitudinal Study
por: Jiménez-Sousa, María Ángeles, et al.
Publicado: (2018)

Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study
por: Gomez-Moreno, Ana Zaida, et al.
Publicado: (2017)

The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design
por: Jiménez-Sousa, María Ángeles, et al.
Publicado: (2018)

CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study
por: Jiménez-Sousa, María Ángeles, et al.
Publicado: (2017)

DBP rs7041 and DHCR7 rs3829251 are Linked to CD4(+) Recovery in HIV Patients on Antiretroviral Therapy
por: Resino, Salvador, et al.
Publicado: (2022)

FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients
por: Pineda-Tenor, Daniel, et al.
Publicado: (2014)

A deficient immune response to SARS-CoV-2 in the nasopharynx is associated with severe COVID-19 pneumonia
por: Pita-Martínez, Carlos, et al.
Publicado: (2023)

Relationship between ITPA polymorphisms and hemolytic anemia in HCV-infected patients after ribavirin-based therapy: a meta-analysis
por: Pineda-Tenor, Daniel, et al.
Publicado: (2015)

Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome
por: Aldámiz-Echevarría, Teresa, et al.
Publicado: (2016)

Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study
por: Guzmán-Fulgencio, María, et al.
Publicado: (2015)

Mx1, OAS1 and OAS2 polymorphisms are associated with the severity of liver disease in HIV/HCV-coinfected patients: A cross-sectional study
por: García-Álvarez, Mónica, et al.
Publicado: (2017)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
por: Vigón, Lorena, et al.
Publicado: (2019)

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
por: Brochado, Óscar, et al.
Publicado: (2021)

Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
por: Medrano, Luz M., et al.
Publicado: (2016)

Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit
por: Álvaro-Meca, Alejandro, et al.
Publicado: (2016)

Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status
por: Garcia-Broncano, Pilar, et al.
Publicado: (2018)

PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study
por: García-Broncano, Pilar, et al.
Publicado: (2014)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Relative telomere length impact on mortality of COVID‐19: Sex differences
por: Virseda‐Berdices, Ana, et al.
Publicado: (2022)

Antiviral therapy of HCV in the cirrhotic and transplant candidate
por: Herrine, Steven K., et al.
Publicado: (2006)

Antiviral Therapy in HCV-infected Decompensated Cirrhotics
por: Danish, Fazal A., et al.
Publicado: (2010)

Strong correlation by ultrasonography of hepatomegaly and the presence of co-infection in HIV/HCV cirrhotic patients
por: Vezozzo, Denise Cerqueira Paranaguá, et al.
Publicado: (2013)

MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection
por: Brochado-Kith, Óscar, et al.
Publicado: (2019)

HCV treatment outcome depends on SNPs of IFNL3-Gene polymorphisms (rs12979860) and cirrhotic changes in liver parenchyma
por: Abd Alla, Mohamed Darwish Ahmed, et al.
Publicado: (2023)

siRNA-Mediated Simultaneous Regulation of the Cellular Innate Immune Response and Human Respiratory Syncytial Virus Replication
por: Martín-Vicente, María, et al.
Publicado: (2019)

Early innate immune response triggered by the human respiratory syncytial virus and its regulation by ubiquitination/deubiquitination processes
por: Martín-Vicente, María, et al.
Publicado: (2022)

DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naïve HIV-infected patients: a retrospective study
por: JIMÉNEZ-SOUSA, María Ángeles, et al.
Publicado: (2019)

Enterococcus gallinarum Spontaneous Bacterial Peritonitis in an HCV Cirrhotic
por: Abidali, Hussein, et al.
Publicado: (2015)

Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk
por: Martín-Escolano, Rubén, et al.
Publicado: (2023)

Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients
por: Álvarez, Beatriz, et al.
Publicado: (2020)

Successful HCV Therapy Reduces Liver Disease Severity and Inflammation Biomarkers in HIV/HCV-Coinfected Patients With Advanced Cirrhosis: A Cohort Study
por: Medrano, Luz Maria, et al.
Publicado: (2021)

Relationship between European Mitochondrial Haplogroups and Chronic Renal Allograft Rejection in Patients with Kidney Transplant
por: JIMÉNEZ-SOUSA, María Angeles, et al.
Publicado: (2014)

Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation
por: Ceballos, Francisco C., et al.
Publicado: (2022)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals (†)
por: Molina-Carrión, Silvia, et al.
Publicado: (2020)

IL-6 rs1800795 polymorphism is associated with septic shock-related death in patients who underwent major surgery: a preliminary retrospective study
por: Jiménez-Sousa, Maria Angeles, et al.
Publicado: (2017)

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)
por: Vázquez-Morón, Sonia, et al.
Publicado: (2019)

Production and characterization of monoclonal antibodies for the detection of the hepatitis C core antigen
por: Vidal-Alcántara, Erick Joan, et al.
Publicado: (2023)

European mitochondrial haplogroups predict liver-related outcomes in patients coinfected with HIV and HCV: a retrospective study
por: Aldámiz-Echevarría, Teresa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6j240jtun8sb5bbj5ih74uprcn